1391925-69-1

Basic information

• Product Name: 3-((4-(1H-indazol-4-yl)-6-morpholino-1,3,5-triazin-2-yl)amino)benzoic acid
• Synonyms: 3-((4-(1H-indazol-4-yl)-6-morpholino-1,3,5-triazin-2-yl)amino)benzoic acid
• CAS NO: 1391925-69-1
• Molecular Weight: 417.427
• Mol File: 1391925-69-1.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: 3-((4-(1H-indazol-4-yl)-6-morpholino-1,3,5-triazin-2-yl)amino)benzoic acid(CAS DataBase Reference)
• NIST Chemistry Reference: 3-((4-(1H-indazol-4-yl)-6-morpholino-1,3,5-triazin-2-yl)amino)benzoic acid(1391925-69-1)
• EPA Substance Registry System: 3-((4-(1H-indazol-4-yl)-6-morpholino-1,3,5-triazin-2-yl)amino)benzoic acid(1391925-69-1)

Safety Data

• Hazardous Substances Data: 1391925-69-1(Hazardous Substances Data)

Upstream product

• 2942-40-7 nitro-4 indazole 
• 885618-33-7 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indazole 
• 1391926-32-1 C₁₄H₁₄ClN₅O₃ 
• 603-83-8 3-nitro-o-tolylamine 
• 41748-71-4 4-aminoindazole 

Downstream Products

• 1391925-55-5 3-((4-(1H-indazol-4-yl)-6-morpholino-1,3,5-triazin-2-yl)amino)-N,N-dimethylbenzamide 

Relevant articles and documents

NOVEL TRIAZINE COMPOUNDS

The present invention relates to novel triazine compounds of formula (1), methods of their preparation, pharmaceutical compositions containing these compounds and the use of these compounds to treat proliferative disorders such as tumors and cancers and also other conditions and disorders related to or associated with dysregulation of PI3 Kinases, PI3 Kinase pathway, mTOR and/ or the mTOR pathway.